Krankenhaus Mara gGmbH
- Address
- Maraweg 21, 33617 Bielefeld, Germany
Krankenhaus Mara gGmbH - Pediatric Epilepsy Research Center
Krankenhaus Mara gGmbH is a specialized research facility focusing on rare and complex pediatric epilepsy syndromes. The center demonstrates particular expertise in long-term safety monitoring and individualized treatment approaches for children with challenging seizure disorders.
- Myoclonic-astatic epilepsy (Doose syndrome) treatment and management
- Long-term safety evaluation of novel antiepileptic therapies
- Individualized dose optimization strategies for pediatric patients
The research team at Krankenhaus Mara gGmbH specializes in conducting open-label extension studies that monitor both safety and efficacy outcomes over extended periods. Their work with Fenfluramine as add-on therapy for rare epilepsy syndromes reflects a commitment to advancing treatment options for patients with refractory seizure disorders, utilizing flexible dosing protocols that can be adapted to individual patient needs and seizure patterns.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Krankenhaus Mara gGmbH
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Long-term Safety Evaluation of Fenfluramine Hydrochloride as Adjunctive Therapy in Patients with Myoclonic Astatic Epilepsy (Doose Syndrome) | Universitaetsklinikum Schleswig-Holstein AöR | Phase II | Not Recruiting | Nov 2021 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fenfluramine Hydrochloride | 1 | Unknown | 2021-11-24 | 2021-11-24 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.